FDA slates Imation's proposals to correct laser facilities
This article was originally published in Clinica
Executive Summary
Proposals put forward by Imation to correct "serious regulatory problems" at its laser imaging facilities in the US have been deemed inadequate by the FDA. The problems relate to the site where the company produces laser imaging systems for use with X-ray, MRI and CT devices.